Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Dicerna Pharmaceuticals (DRNA)

Dicerna Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRNA
DateTimeSourceHeadlineSymbolCompany
14/02/202211:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
10/01/202222:00Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DRNADicerna Pharmaceuticals Inc
03/01/202211:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
29/12/202121:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:18Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:14Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:06Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202116:04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202115:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202115:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:35Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRNADicerna Pharmaceuticals Inc
28/12/202114:04Business WireNovo Nordisk Announces Completion of Dicerna Pharmaceuticals AcquisitionNASDAQ:DRNADicerna Pharmaceuticals Inc
27/12/202113:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
27/12/202113:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DRNADicerna Pharmaceuticals Inc
25/12/202113:00Business WireDicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire DicernaNASDAQ:DRNADicerna Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DRNA